| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,903 |
1,831 |
$121K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,228 |
1,179 |
$82K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,213 |
1,153 |
$57K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
567 |
540 |
$51K |
| 87428 |
|
569 |
552 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
876 |
848 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
251 |
241 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
226 |
219 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
250 |
151 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
27 |
26 |
$1K |
| 87430 |
|
82 |
81 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
56 |
53 |
$829.12 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
16 |
$499.88 |
| 81002 |
|
13 |
12 |
$17.47 |
| 99000 |
|
107 |
105 |
$0.00 |